Vivani Medical (VANI) Free Cash Flow (2014 - 2026)
Vivani Medical (VANI) posted quarterly Free Cash Flow of -$6.2 million for Q1 2026, down 19.95% year-over-year from -$7.7 million in Q1 2025, and up 11.35% quarter-over-quarter from -$7.0 million in Q4 2025.
Vivani Medical (VANI) Free Cash Flow (2014 - 2026) Analysis & Trends
Vivani Medical's Free Cash Flow history runs 13 years deep, the most recent figure standing at -$6.2 million for Q1 2026.
- In Q1 2026, Free Cash Flow fell 19.95% year-over-year to -$6.2 million; the TTM figure through Mar 2026 stood at -$26.5 million (down 21.58% YoY), while the FY2025 annual figure was -$25.5 million, down 19.45% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$6.2 million, up from -$7.0 million in the prior quarter.
- The five-year high for Free Cash Flow was -$3.2 million in Q1 2022, with the low at -$7.8 million in Q3 2023.
- The 5-year median for Free Cash Flow is -$5.7 million (2024), against an average of -$5.7 million.
- The sharpest annual moves came in 2022 and 2024: Free Cash Flow sank 312.08% in 2022, then soared 32.97% in 2024.
- Vivani Medical's Free Cash Flow stood at -$5.3 million in 2022, then grew by 20.18% to -$4.2 million in 2023, then slumped by 44.6% to -$6.1 million in 2024, then declined by 14.49% to -$7.0 million in 2025, then increased by 11.35% to -$6.2 million in 2026.
- Business Quant data shows VANI's Free Cash Flow at -$6.2 million in Q1 2026, -$7.0 million in Q4 2025, and -$7.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -563.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 437.80 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 292.04 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 433.84 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -95.09 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 477.44 Mn |
| 10 | Vivani Medical | 120.18 Mn | 100.29 Mn | - | -6.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -6.13 Mn |
| Jun 30, 2026 | -6.13 Mn |
| Mar 31, 2026 | -6.20 Mn |
| Mar 31, 2026 | -6.20 Mn |
| Dec 31, 2025 | -6.99 Mn |
| Dec 31, 2025 | -6.99 Mn |
| Sep 30, 2025 | -7.17 Mn |
| Sep 30, 2025 | -7.17 Mn |
| Jun 30, 2025 | -6.16 Mn |
| Jun 30, 2025 | -6.16 Mn |
| Mar 31, 2025 | -5.17 Mn |
| Mar 31, 2025 | -5.17 Mn |
| Dec 31, 2024 | -6.11 Mn |
| Dec 31, 2024 | -6.11 Mn |
| Sep 30, 2024 | -5.70 Mn |
| Sep 30, 2024 | -5.70 Mn |
| Jun 30, 2024 | -4.84 Mn |
| Jun 30, 2024 | -4.84 Mn |
| Mar 31, 2024 | -4.69 Mn |
| Mar 31, 2024 | -4.69 Mn |